Bullish & Foolish
Full LMRI fundamentals All 466 on the Survival Watch

LMRILumexa Imaging Holdings, Inc.

Is Lumexa Imaging Holdings struggling financially?

Yes, by its own account. Lumexa Imaging Holdings told the SEC on 30 Mar 2026, in Form 10-K, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed Mar 2026

19/100

Critical

Sector
Biotech/Pharma
Market cap
$1.2B
Source filing
10-K 30 Mar 2026
Balance sheet
30 Jun 2026

Cash runway

Not estimable

The latest filings do not carry the cash or cash-flow lines needed to estimate a runway. Publishing a number here would mean inventing one.

What it reported

Cash and short-term investments

$69.7M

What Lumexa Imaging Holdings told the SEC

…of the consolidated financial statements. Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for a reasonable period of time. We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit,…

Lumexa Imaging Holdings, Inc., Form 10-K, filed 30 Mar 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

  • Debt pressure is material Debt is large against the cash on hand while the business generates little to service it, which puts lenders ahead of shareholders in the queue.
  • 38.1% share-count increase The company issued stock. Each share now owns 27.6% less of the business than a year ago, before any change in the price.

Other Biotech/Pharma companies that filed the doubt